Soluble metalloendopeptidases and neuroendocrine signaling.

Peptidases play a vital and often highly specific role in the physiological and pathological generation and termination of peptide hormone signals. The thermolysin-like family of metalloendopeptidases involved in the extracellular processing of neuroendocrine and cardiovascular peptides are of particular significance, reflecting both their specificity for particular peptide substrates and their utility as therapeutic targets. Although the functions of the membrane-bound members of this family, such as angiotensin-converting enzyme and neutral endopeptidase, are well established, a role for the predominantly soluble family members in peptide metabolism is only just emerging. This review will focus on the biochemistry, cell biology, and physiology of the soluble metalloendopeptidases EC 3.4.24.15 (thimet oligopeptidase) and EC 3.4.24.16 (neurolysin), as well as presenting evidence that both peptidases play an important role in such diverse functions as reproduction, nociception, and cardiovascular homeostasis.

[1]  A. Kato,et al.  Cloning, amino acid sequence and tissue distribution of porcine thimet oligopeptidase. A comparison with soluble angiotensin-binding protein. , 1994, European journal of biochemistry.

[2]  A. Berger,et al.  On the size of the active site in proteases. I. Papain. , 1967, Biochemical and biophysical research communications.

[3]  F. Cozzolino,et al.  A novel secretory pathway for interleukin‐1 beta, a protein lacking a signal sequence. , 1990, The EMBO journal.

[4]  J. Roberts,et al.  Substrate specificity differences between recombinant rat testes endopeptidase EC 3.4.24.15 and the native brain enzyme. , 1995, Biochemical and biophysical research communications.

[5]  M. Orłowski,et al.  A soluble metalloendopeptidase from rat brain. Purification of the enzyme and determination of specificity with synthetic and natural peptides. , 1983, European journal of biochemistry.

[6]  A. Beaudet,et al.  Light and Electron Microscopic Localization of the Neutral Metalloendopeptidase EC 3.4.24.16 in the Mesencephalon of the Rat , 1992, The European journal of neuroscience.

[7]  E. Daniel,et al.  Role of endopeptidase 3.4.24.16 in the catabolism of neurotensin, in vivo, in the vascularly perfused dog ileum , 1994, British journal of pharmacology.

[8]  A. Barrett,et al.  Chicken liver Pz-peptidase, a thiol-dependent metallo-endopeptidase. , 1990, The Biochemical journal.

[9]  A. Pierotti,et al.  Expression of the thimet oligopeptidase gene is regulated by positively and negatively acting elements. , 2000, DNA and cell biology.

[10]  F. Checler,et al.  Development of the First Potent and Selective Inhibitor of the Zinc Endopeptidase Neurolysin Using a Systematic Approach Based on Combinatorial Chemistry of Phosphinic Peptides* , 1996, The Journal of Biological Chemistry.

[11]  F. Checler Processing of the β‐Amyloid Precursor Protein and Its Regulation in Alzheimer's Disease , 1995 .

[12]  C. Ferrario,et al.  Release of angiotensin-(1-7) from the rat hindlimb: influence of angiotensin-converting enzyme inhibition. , 2000, Hypertension.

[13]  P. Xu,et al.  Human endopeptidase (THOP1) is localized on chromosome 19 within the linkage region for the late-onset alzheimer disease AD2 locus. , 1996, Genomics.

[14]  T. Saido,et al.  Metabolic Regulation of Brain Aβ by Neprilysin , 2001, Science.

[15]  M. Orłowski,et al.  Immunohistochemical localization of endopeptidase 24.15 in rat trachea, lung tissue, and alveolar macrophages. , 1990, American journal of respiratory cell and molecular biology.

[16]  J. Rossier,et al.  Brain Endo‐Oligopeptidase A, a Putative Enkephalin Converting Enzyme , 1987, Journal of neurochemistry.

[17]  I. Clarke,et al.  Peptidases that Degrade Gonadotropin‐Releasing Hormone: Influence on LH Secretion in the Ewe , 1997, Journal of neuroendocrinology.

[18]  S. Hirose,et al.  Molecular cloning of porcine soluble angiotensin-binding protein. , 1992, The Journal of biological chemistry.

[19]  M. Orłowski,et al.  Endopeptidase 24.15 from rat testes. Isolation of the enzyme and its specificity toward synthetic and natural peptides, including enkephalin-containing peptides. , 1989, The Biochemical journal.

[20]  M. E. Lewis,et al.  Endogenous opioids: biology and function. , 1984, Annual review of neuroscience.

[21]  J. Roberts,et al.  Evidence for a two-step mechanism of gonadotropin-releasing hormone metabolism by prolyl endopeptidase and metalloendopeptidase EC 3.4.24.15 in ovine hypothalamic extracts. , 1994, The Journal of biological chemistry.

[22]  R. Barbour,et al.  Purification and cloning of amyloid precursor protein β-secretase from human brain , 1999, Nature.

[23]  J P Vincent,et al.  Purification and characterization of a novel neurotensin-degrading peptidase from rat brain synaptic membranes. , 1986, The Journal of biological chemistry.

[24]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[25]  F. Checler,et al.  Rat kidney endopeptidase 24.16. Purification, physico-chemical characteristics and differential specificity towards opiates, tachykinins and neurotensin-related peptides. , 1993, European journal of biochemistry.

[26]  M. Orłowski,et al.  Synaptosomal Membrane‐Bound Form of Endopeptidase‐24.15 Generates Leu‐Enkephalin from Dynorphin 1‐8, α‐ and β‐Neoendorphin, and Met‐Enkephalin from Met‐Enkephalin‐Arg6‐Gly7‐Leu , 1987 .

[27]  L. Hersh,et al.  Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by Degradation* , 1998, The Journal of Biological Chemistry.

[28]  B. Roques,et al.  Contribution of endopeptidase 3.4.24.15 to central neurotensin inactivation. , 1997, European journal of pharmacology.

[29]  A. Goldberg,et al.  Major Histocompatibility Complex Class I-presented Antigenic Peptides Are Degraded in Cytosolic Extracts Primarily by Thimet Oligopeptidase* , 2001, Journal of Biological Chemistry.

[30]  T. Davis,et al.  Peptidases in the CNS: formation of biologically active, receptor-specific peptide fragments. , 1993, Critical reviews in neurobiology.

[31]  J. Bourguignon,et al.  Early prepubertal ontogeny of pulsatile gonadotropin-releasing hormone (GnRH) secretion: I. Inhibitory autofeedback control through prolyl endopeptidase degradation of GnRH. , 1999, Endocrinology.

[32]  D. Selkoe,et al.  Neurons Regulate Extracellular Levels of Amyloid β-Protein via Proteolysis by Insulin-Degrading Enzyme , 2000, The Journal of Neuroscience.

[33]  S. Jacchieri,et al.  Structural features that make oligopeptides susceptible substrates for hydrolysis by recombinant thimet oligopeptidase. , 1997, The Biochemical journal.

[34]  D. Tambourgi,et al.  Secretion of a neuropeptide-metabolizing enzyme similar to endopeptidase 22.19 by glioma C6 cells. , 1993, Biochemical and biophysical research communications.

[35]  M. Orłowski,et al.  A soluble metalloendopeptidase from rat brain , 1983 .

[36]  R. Bodnar,et al.  Antinociceptive properties of inhibitors of endopeptidase 24.15. , 1991, The International journal of neuroscience.

[37]  M. Norman,et al.  Metalloendopeptidases EC 3.4.24.15 and EC 3.4.24.16 And Bradykinin B2 Receptors Do Not Play Important Roles In Renal Wrap Hypertension In Rabbits , 2001, Clinical and experimental pharmacology & physiology.

[38]  D. Steiner,et al.  Post-translational proteolysis in polypeptide hormone biosynthesis. , 1982, Annual review of physiology.

[39]  M. Orłowski,et al.  Immunocytochemical localization of endopeptidase 24.15 in rat brain , 1992, Brain Research.

[40]  D. Grandy,et al.  Orphanin FQ: A Neuropeptide That Activates an Opioidlike G Protein-Coupled Receptor , 1995, Science.

[41]  B. Roques,et al.  Effect of a novel selective and potent phosphinic peptide inhibitor of endopeptidase 3.4.24.16 on neurotensin‐induced analgesia and neuronal inactivation , 1997, British journal of pharmacology.

[42]  C. Prange,et al.  Human endopeptidase 24.15 (THOP1) is localized on chromosome 19p13.3 and is excluded from the linkage region for late-onset Alzheimer disease. , 1998, Genomics.

[43]  J. Ayala,et al.  Endopeptidase-24.15 in rat hypothalamic/pituitary/gonadal axis , 1991, Molecular and Cellular Endocrinology.

[44]  B. Roques,et al.  Association of aminopeptidase N and endopeptidase 24.15 inhibitors potentiate behavioral effects mediated by nociceptin/orphanin FQ in mice , 1997, FEBS letters.

[45]  N. Rawlings,et al.  Evolutionary families of peptidases. , 1993, The Biochemical journal.

[46]  J. Roberts,et al.  The role of EC 3.4.24.15 in the post-secretory regulation of peptide signals. , 1994, Biochimie.

[47]  C. Pineau,et al.  Distribution of thimet oligopeptidase (E.C. 3.4.24.15) in human and rat testes. , 1999, Journal of cell science.

[48]  C. Nemeroff,et al.  Neurotensin-like immunoreactivity in cerebrospinal fluid of patients with schizophrenia, depression, anorexia nervosa-bulimia, and premenstrual syndrome. , 1989, The Journal of neuropsychiatry and clinical neurosciences.

[49]  A. Beaudet,et al.  Comparative fine structural distribution of endopeptidase 24.15 (EC3.4.24.15) and 24.16 (EC3.4.24.16) in rat brain , 2001, The Journal of comparative neurology.

[50]  C. Eckman,et al.  Degradation of the Alzheimer's Amyloid β Peptide by Endothelin-converting Enzyme* , 2001, The Journal of Biological Chemistry.

[51]  J. Vane,et al.  Conversion of Angiotensin I to Angiotensin II , 1967, Nature.

[52]  Characterization of an endooligopeptidase A‐like protein in PC12 cells: Activity modulation by cAMP but not by basic fibroblast growth factor , 1995, Journal of cellular biochemistry.

[53]  J. Roberts,et al.  Secretion of metalloendopeptidase 24.15 (EC 3.4.24.15). , 1999, DNA and cell biology.

[54]  L. Juliano,et al.  Thimet oligopeptidase and the stability of MHC class I epitopes in macrophage cytosol. , 1999, Biochemical and biophysical research communications.

[55]  E. Davie,et al.  Rabbit liver microsomal endopeptidase with substrate specificity for processing proproteins is structurally related to rat testes metalloendopeptidase 24.15. , 1993, The Journal of biological chemistry.

[56]  J. Roberts,et al.  Molecular cloning and primary structure of rat testes metalloendopeptidase EC 3.4.24.15. , 1990, Biochemistry.

[57]  Takehiko Hosoiri,et al.  Targeting of Endopeptidase 24.16 to Different Subcellular Compartments by Alternative Promoter Usage* , 1997, The Journal of Biological Chemistry.

[58]  H. Gainer,et al.  The enzymology and intracellular organization of peptide precursor processing: the secretory vesicle hypothesis. , 1985, Neuroendocrinology.

[59]  N. Jaiswal,et al.  Angiotensin-(1-7): a new hormone of the angiotensin system. , 1991, Hypertension.

[60]  L. Juliano,et al.  Characterization of thiol‐, aspartyl‐, and thiol‐metallo‐peptidase activities in Madin‐Darby canine kidney cells , 2000, Journal of Cellular Biochemistry.

[61]  G. Fink,et al.  Endopeptidase EC 3.4.24.15 Presence in the Rat Median Eminence and Hypophysial Portal Blood and its Modulation of the Luteinizing Hormone Surge , 1997, Journal of neuroendocrinology.

[62]  J. Fallon,et al.  Neurotensin and cholecystokinin coexistence within neurons of the ventral mesencephalon: projections to forebrain , 2004, Experimental Brain Research.

[63]  J. Bourguignon,et al.  Gonadotropin releasing hormone inhibitory autofeedback by subproducts antagonist at N-methyl-D-aspartate receptors: a model of autocrine regulation of peptide secretion. , 1994, Endocrinology.

[64]  K. Suzuki,et al.  Thimet oligopeptidase cleaves the full-length Alzheimer amyloid precursor protein at a beta-secretase cleavage site in COS cells. , 1999, Journal of biochemistry.

[65]  A. Igarashi,et al.  Angiotensin-converting Enzyme Degrades Alzheimer Amyloid β-Peptide (Aβ); Retards Aβ Aggregation, Deposition, Fibril Formation; and Inhibits Cytotoxicity* , 2001, The Journal of Biological Chemistry.

[66]  B. Clineschmidt,et al.  Neurotensin: antinocisponsive action in rodents. , 1979, European journal of pharmacology.

[67]  C. L. Silva,et al.  Thimet oligopeptidase (EC 3.4.24.15), a novel protein on the route of MHC class I antigen presentation. , 1999, Biochemical and biophysical research communications.

[68]  A. Coquerel,et al.  Potentiation by thiorphan and bestatin of the naloxone-insensitive analgesic effects of neurotensin and neuromedin n , 1988, Neurochemistry International.

[69]  J. W. Tullai,et al.  The association of metalloendopeptidase EC 3.4.24.15 at the extracellular surface of the AtT-20 cell plasma membrane , 1999, Brain Research.

[70]  J. Costentin,et al.  Effects of thiorphan, bestatin and a novel metallopeptidase inhibitor JMV 390-1 on the recovery of neurotensin and neuromedin N released from mouse hypothalamus , 1992, Neuroscience Letters.

[71]  A. Camargo,et al.  Preparation, assay, and partial characterization of a neutral endopeptidase from rabbit brain. , 1973, Biochemistry.

[72]  A. Beaudet,et al.  Distinct Properties of Neuronal and Astrocytic Endopeptidase 3.4.24.16: A Study on Differentiation, Subcellular Distribution, and Secretion Processes , 1996, The Journal of Neuroscience.

[73]  G. Abbenante,et al.  Development and characterization of novel potent and stable inhibitors of endopeptidase EC 3.4.24.15. , 2000, The Biochemical journal.

[74]  F Wold,et al.  In vivo chemical modification of proteins (post-translational modification). , 1981, Annual review of biochemistry.

[75]  A. Barrett,et al.  A distinct thimet peptidase from rat liver mitochondria , 1990, FEBS letters.

[76]  A. K. Carmona,et al.  Thimet oligopeptidase EC 3.4.24.15 is a major liver kininase. , 2000, Life sciences.

[77]  R. Bodnar,et al.  Increases in opioid-mediated swim antinociception following endopeptidase 24.15 inhibition , 1991, Physiology & Behavior.

[78]  N. Hooper,et al.  Angiotensin converting enzyme: implications from molecular biology for its physiological functions. , 1991, The International journal of biochemistry.

[79]  A. Camargo,et al.  Presence of endo-oligopeptidase (EC 3.4.22.19), a putative neuropeptide-metabolizing endopeptidase in cells of the immune system , 1992, Journal of Neuroimmunology.

[80]  C. Abraham,et al.  Identification of a metalloprotease from Alzheimer's disease brain able to degrade the beta-amyloid precursor protein and generate amyloidogenic fragments. , 1994, Biochemistry.

[81]  F. Checler,et al.  Specific inhibition of endopeptidase 24.16 by dipeptides. , 1991, European journal of biochemistry.

[82]  M. D. Gomes,et al.  Species specificity of thimet oligopeptidase (EC 3.4.24.15). , 1996, Biological chemistry Hoppe-Seyler.

[83]  L. Juliano,et al.  Structural requirements of bioactive peptides for interaction with endopeptidase 22.19 , 1994, Neuropeptides.

[84]  F. Checler,et al.  Stably Transfected Human Cells Overexpressing Rat Brain Endopeptidase 3.4.24.16: Biochemical Characterization of the Activity and Expression of Soluble and Membrane‐Associated Counterparts , 1997, Journal of neurochemistry.

[85]  F. Checler,et al.  Peripheral inactivation of neurotensin. Isolation and characterization of a metallopeptidase from rat ileum. , 1988, European journal of biochemistry.

[86]  M. Orłowski,et al.  Inhibition of endopeptidase 24.15 slows the in vivo degradation of luteinizing hormone-releasing hormone. , 1989, The Journal of pharmacology and experimental therapeutics.

[87]  S. Snyder,et al.  Enkephalin convertase: purification and characterization of a specific enkephalin-synthesizing carboxypeptidase localized to adrenal chromaffin granules. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[88]  J. Palacios,et al.  Neurotensin receptors are located on dopamine-containing neurones in rat midbrain , 1981, Nature.

[89]  J. Roberts,et al.  Thiol Activation of Endopeptidase EC 3.4.24.15 , 1997, The Journal of Biological Chemistry.

[90]  M. Orłowski,et al.  Substrate-related potent inhibitors of brain metalloendopeptidase. , 1988, Biochemistry.

[91]  J. Mcdermott,et al.  Peptidases involved in the catabolism of neurotensin: Inhibitor studies using superfused rat hypothalamic slices , 1986, Peptides.

[92]  E. Mascha,et al.  Effects of a Metalloendopeptidase‐24.15 Inhibitor on Renal Hemodynamics and Function in Rats , 1994, Hypertension.

[93]  M. Goedert,et al.  Examination of the role of endopeptidase 3.4.24.15 in Aβ secretion by human transfected cells , 1997, British journal of pharmacology.

[94]  B. Roques,et al.  Nociceptin/Orphanin FQ Metabolism: Role of Aminopeptidase and Endopeptidase 24.15 , 1997, Journal of neurochemistry.

[95]  R. Skidgel Bradykinin‐Degrading Enzymes: Structure, Function, Distribution, and Potential Roles in Cardiovascular Pharmacology , 1992, Journal of cardiovascular pharmacology.

[96]  T. Davis,et al.  Acute administration of neuroleptics decreases neurotensin metabolism on intact, regional rat brain slices. , 1994, The Journal of pharmacology and experimental therapeutics.

[97]  J. Mcdermott,et al.  Human brain peptidase activity with the specificity to generate the N-terminus of the Alzheimer beta-amyloid protein from its precursor. , 1992, Biochemical and biophysical research communications.

[98]  Y. Ibata,et al.  The location of LH-RH neurons in the rat hypothalamus and their pathways to the median eminence , 1979, Cell and Tissue Research.

[99]  D. Walsh,et al.  Endopeptidase 3.4.24.11 converts N-1-(R,S)carboxy-3-phenylpropyl-Ala-Ala-Phe-p-carboxyanilide into a potent inhibitor of angiotensin-converting enzyme. , 1993, The Biochemical journal.

[100]  F. Checler,et al.  Molecular Cloning and Expression of Rat Brain Endopeptidase 3.4.24.16 (*) , 1995, The Journal of Biological Chemistry.

[101]  P. Emson,et al.  Involvement of Endo‐Oligopeptidases A and B in the Degradation of Neurotensin by Rabbit Brain , 1984, Journal of neurochemistry.

[102]  J. S. Jacobsen,et al.  Evaluation of Cathepsins D and G and EC 3.4.24.15 as Candidate β‐Secretase Proteases Using Peptide and Amyloid Precursor Protein Substrates , 1996, Journal of neurochemistry.

[103]  Shin‐Rong Hwang,et al.  Proteases and the emerging role of protease inhibitors in prohormone processing , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[104]  James L. Roberts,et al.  Differential subcellular distribution of neurolysin (EC 3.4.24.16) and thimet oligopeptidase (EC 3.4.24.15) in the rat brain , 1999, Brain Research.

[105]  M. Orłowski,et al.  Evidence that enzymatic conversion of N-[1(R,S)-carboxy-3-phenylpropyl]-Ala-Ala-Phe-p-aminobenzoate, a specific inhibitor of endopeptidase 24.15, to N-[1 (R,S)-carboxy-3-phenylpropyl]-Ala-Ala is necessary for inhibition of angiotensin converting enzyme , 1993, Peptides.

[106]  D. Rodgers,et al.  Structure of neurolysin reveals a deep channel that limits substrate access , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[107]  C. Nemeroff,et al.  Reduced CSF neurotensin concentration in drug-free schizophrenic patients , 1988, Schizophrenia Research.

[108]  R. Evans,et al.  Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits , 1996, British journal of pharmacology.

[109]  A. Beaudet,et al.  Distribution of neurotensin binding sites in rat brain: A light microscopic radioautographic study using monoiodo [125I]Tyr3-neurotensin , 1987, Neuroscience.

[110]  J. Krause,et al.  Luteinizing hormone-releasing hormone peptidase activities in discrete hypothalamic regions and anterior pituitary of the rat: apparent regulation during the prepubertal period and first estrous cycle at puberty. , 1982, Endocrinology.

[111]  J. Martignetti,et al.  The Neuropeptide Processing Enzyme EC 3.4.24.15 Is Modulated by Protein Kinase A Phosphorylation* , 2000, The Journal of Biological Chemistry.

[112]  A. Turner,et al.  Isoforms of endothelin-converting enzyme: why and where? , 1998, Trends in pharmacological sciences.

[113]  S. Hunt,et al.  Localization of Endo‐Oligopeptidase (EC 3.4.22.19) in the Rat Nervous Tissue , 1990, Journal of neurochemistry.

[114]  B. A. Lessley,et al.  Identification and distribution of Pz-peptidases A and B in human semen. , 1985, Journal of andrology.

[115]  R. Evans,et al.  Role of angiotensin converting enzyme in the vascular effects of an endopeptidase 24.15 inhibitor , 1995, British journal of pharmacology.

[116]  B. Horsthemke,et al.  Characterization of a nonchymotrypsin-like endopeptidase from anterior pituitary that hydrolyzes luteining hormone-releasing hormone at the tyrosyl-glycine and histidyl-tryptophan bonds. , 1980, Biochemistry.

[117]  A. Beaudet,et al.  Confocal microscopy reveals thimet oligopeptidase (EC 3.4.24.15) and neurolysin (EC 3.4.24.16) in the classical secretory pathway. , 1999, DNA and cell biology.

[118]  D. Ganten,et al.  Converting enzyme determines plasma clearance of angiotensin-(1-7). , 1998, Hypertension.

[119]  F. Checler,et al.  Colocalization of neurotensin receptors and of the neurotensin- degrading enzyme endopeptidase 24-16 in primary cultures of neurons , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[120]  N. Rawlings,et al.  Thimet oligopeptidase and oligopeptidase M or neurolysin. , 1995, Methods in enzymology.

[121]  E. Genden,et al.  Inhibition of Endopeptidase‐24.15 Decreases Blood Pressure in Normotensive Rats , 1991, Hypertension.

[122]  J. Bourguignon,et al.  Early Prepubertal Ontogeny of Pulsatile Gonadotropin-Releasing Hormone (GnRH) Secretion: I. Inhibitory Autofeedback Control through Prolyl Endopeptidase Degradation of GnRH1. , 1999, Endocrinology.

[123]  M. Glucksman,et al.  Zinc Coordination and Substrate Catalysis within the Neuropeptide Processing Enzyme Endopeptidase EC 3.4.24.15 , 1999, The Journal of Biological Chemistry.

[124]  R. Mains,et al.  Peptide alpha-amidation. , 1988, Annual review of physiology.

[125]  M. Orłowski,et al.  Soluble metalloendopeptidase from rat brain: action on enkephalin-containing peptides and other bioactive peptides. , 1985, Endocrinology.

[126]  C. Nemeroff,et al.  SUBNORMAL CSF LEVELS OF NEUROTENSIN IN A SUBGROUP OF SCHIZOPHRENICS AND NORMALIZATION AFTER NEUROLEPTIC TREATMENT , 1982, The American journal of psychiatry.

[127]  A. Turner,et al.  Molecular pharmacology of endothelin converting enzymes. , 1996, Biochemical pharmacology.

[128]  M. Orłowski,et al.  Inhibition of endopeptidase 24.15 greatly increases the release of luteinizing hormone and follicle stimulating hormone in response to luteinizing hormone/releasing hormone. , 1990, The Journal of pharmacology and experimental therapeutics.

[129]  F. Checler,et al.  Neurotensin metabolism in various tissues of central and peripheral origins: ubiquitous involvement of a novel neurotensin degrading metalloendopeptidase. , 1988, Biochimie.

[130]  L. Juliano,et al.  Substrate specificity characterization of recombinant metallo oligo-peptidases thimet oligopeptidase and neurolysin. , 2001, Biochemistry.

[131]  N. Rawlings,et al.  [32] Thimet oligopeptidase and oligopeptidase M or neurolysin , 1995 .

[132]  R. Mentlein,et al.  Purification of the main somatostatin-degrading proteases from rat and pig brains, their action on other neuropeptides, and their identification as endopeptidases 24.15 and 24.16. , 1992, European journal of biochemistry.

[133]  A. Barrett,et al.  Human thimet oligopeptidase. , 1993, The Biochemical journal.

[134]  B. Roques Cell surface metallopeptidases involved in blood pressure regulation: structure, inhibition and clinical perspectives. , 1998, Pathologie-biologie.

[135]  B. Horsthemke,et al.  Substrate specificity of an adenohypophyseal endopeptidase capable of hydrolyzing luteinizing hormone-releasing hormone: preferential cleavage of peptide bones involving the carboxyl terminus of hydrophobic and basic amino acids. , 1982, Biochemistry.

[136]  M. Orłowski,et al.  Endopeptidase‐24.15 Is the Primary Enzyme that Degrades Luteinizing Hormone Releasing Hormone Both In Vitro and In Vivo , 1988, Journal of neurochemistry.

[137]  O. Carretero,et al.  Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivo. , 1987, Kidney international.

[138]  L. Hersh,et al.  Endopeptidase 24.16B , 1995, The Journal of Biological Chemistry.

[139]  K. Nakagawa,et al.  Tissue Distribution and Subcellular Localization of Rabbit Liver Metalloendopeptidase , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[140]  Conversion and inactivation of opioid peptides by rabbit brain endo-oligopeptidase A. , 1985, Biochemical and biophysical research communications.

[141]  R. Mentlein,et al.  Endopeptidases 24.16 and 24.15 Are Responsible for the Degradation of Somatostatin, Neurotensin, and Other Neuropeptides by Cultivated Rat Cortical Astrocytes , 1994, Journal of neurochemistry.

[142]  Marc Parmentier,et al.  Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor , 1995, Nature.

[143]  J. Treanor,et al.  Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.

[144]  J. Ayala,et al.  An Inhibitor of Endopeptidase‐24.15 Blocks the Degradation of Intraventricularly Administered Dynorphins , 1990, Journal of neurochemistry.

[145]  J. Sloane,et al.  Metalloendopeptidase EC 3.4.24.15 Is Necessary for Alzheimer’s Amyloid-β Peptide Degradation* , 1999, The Journal of Biological Chemistry.

[146]  F. Checler,et al.  Inactivation of Neurotensin by Rat Brain Synaptic Membranes Partly Occurs Through Cleavage at the Arg8‐Arg9 Peptide Bond by a Metalloendopeptidase , 1985, Journal of neurochemistry.

[147]  C. Nemeroff,et al.  The Neurobiology of Neurotensin , 1992 .

[148]  F. Checler,et al.  Development of Highly Potent and Selective Phosphinic Peptide Inhibitors of Zinc Endopeptidase 24-15 Using Combinatorial Chemistry (*) , 1995, The Journal of Biological Chemistry.

[149]  P. Perlmutter,et al.  Bradykinin analogues with β‐amino acid substitutions reveal subtle differences in substrate specificity between the endopeptidases EC 3.4.24.15 and EC 3.4.24.16 , 2000, Journal of peptide science : an official publication of the European Peptide Society.

[150]  T. Hökfelt,et al.  Occurrence of neurotensinlike immunoreactivity in subpopulations of hypothalamic, mesencephalic, and medullary catecholamine neurons , 1984, The Journal of comparative neurology.

[151]  F. Checler,et al.  Tissue distribution of a novel neurotensin-degrading metallopeptidase. An immunological approach using monospecific polyclonal antibodies. , 1989, The Biochemical journal.

[152]  J. Roberts,et al.  Neuropeptide specificity and inhibition of recombinant isoforms of the endopeptidase 3.4.24.16 family: comparison with the related recombinant endopeptidase 3.4.24.15. , 1998, Biochemical and biophysical research communications.

[153]  A. Barrett,et al.  Characterization of a Mitochondrial Metallopeptidase Reveals Neurolysin as a Homologue of Thimet Oligopeptidase (*) , 1995, The Journal of Biological Chemistry.

[154]  A. Turner,et al.  Purification and properties of a neurotensin-degrading endopeptidase from pig brain. , 1991, The Biochemical journal.

[155]  R. Evans,et al.  A novel stable inhibitor of endopeptidases EC 3.4.24.15 and 3.4.24.16 potentiates bradykinin-induced hypotension. , 2000, Hypertension.

[156]  N. Seidah,et al.  Proprotein Convertases , 2011, Methods in Molecular Biology.

[157]  C. Boustead,et al.  Cell-surface peptidases in health and disease , 1997 .

[158]  N. Rawlings,et al.  Thimet oligopeptidase: similarity to 'soluble angiotensin II-binding protein' and some corrections to the published amino acid sequence of the rat testis enzyme. , 1993, The Biochemical journal.

[159]  D. Tambourgi,et al.  Molecular and immunochemical evidences demonstrate that endooligopeptidase A is the predominant cytosolic oligopeptidase of rabbit brain. , 2000, Biochemical and biophysical research communications.

[160]  N. Seidah,et al.  Mammalian subtilisin/kexin isozyme SKI-1: A widely expressed proprotein convertase with a unique cleavage specificity and cellular localization. , 1999, Proceedings of the National Academy of Sciences of the United States of America.